A Pet Obesity Task Force, the first of its kind in the country, has been launched at the European Pet Obesity Conference, hosted by Hill’s Pet Nutrition to help tackle the growing number of obese and overweight pets and put in place strategies to help overcome the condition.
The Task Force hopes to raise awareness of the growing health implications of obese and overweight pets, such as diabetes and osteoarthritis. The fact that pets are obese or overweight is often overlooked by owners and the group also aims to encourage them to identify weight problems and seek appropriate advice from vets.
Mark Evans, chief veterinary adviser at the RSPCA, who will be sitting on the board, comments: “We’ve been trying to treat and prevent pet obesity for 20 years, but the problem hasn’t gone away. In fact it seems to have got worse despite everyone’s efforts. It’s incredibly frustrating. So, is there any point in fighting on in the same old way if we’re not winning the battle?
“Let’s take a step back, review our knowledge, re-evaluate our approaches, think outside the box and innovate. What could we learn from social scientists, human psychologists and others engaged in trying to tackle the very same problem in people – especially children?”
Members of the Pet Obesity Task Force include:
Mark Evans, chief veterinary adviser, RSPCA BVetMed MRCVS Professor John Innes BVSc PhD CertVR DSAS(Orth) MRCVS Professor Danielle Gunn-Moore BSc BVM&S PhD MACVSc MRCVS Daniel Chan DVM DipACVECC DipACVN MRCVS Nicola Ackerman BSc(Hons) RVN Cert SAN MBVNA Rachel Casey BVMS Dip(AS)CABC MRCVS Dr Ian Campbell GP Mike Jessop BVetMed MRCVS Dr Jacques Debraekeleer DVM, DipECVCN Simon Wheeler Head of marketing at Petplan
The Disciplinary Committee of the Royal College of Veterinary Surgeons has suspended a veterinary surgeon for a period of three months for practising veterinary surgery while not registered with the College.
At a hearing which concluded on 9 September, Silke Birgitt Lindridge, of the Consett Veterinary Centre, Medomsley Road, Consett, County Durham, was found guilty of disgraceful conduct in a professional respect for practising when she ought to have known that her name had been removed from the RCVS Register for non-payment of fees.
The Committee heard that Mrs Lindridge, who qualified as a veterinary surgeon at the University of Berlin in 1997, had returned to Germany whilst on maternity leave in September 2006 but had continued to be the sole principal of two practices, the Consett Veterinary Centre, and the Winlaton Veterinary Centre in Tyne and Wear. She had continued to run the practices whilst in Germany, and had returned to the UK on several occasions during 2007, when she practised veterinary surgery on small animals and horses. She had not been registered with the College for the period between 5 June 2006 and 2 April 2008.
To practise veterinary surgery when unregistered is a criminal offence. However, after consultation with the Crown Prosecution Service, a decision was taken that it was not in the public interest to prosecute Mrs Lindridge and that the matter should be left with the RCVS Disciplinary Committee.
Mrs Lindridge claimed not to be aware that she was unregistered, stating that a fee notice and reminder, as well as a telephone call and correspondence from the College about her registration status, had not been brought to her attention by her practice administrators. The Committee accepted that she had not known, but decided that, as registration was a professional obligation, Mrs Lindridge should have known that her name had been removed from the Register, a charge that Mrs Lindridge accepted. The Committee felt that: "The failure of Mrs Lindridge to put in place proper systems for the administration of her practice, including the payment of her annual retention fee... was lamentable." The way in which the practice had paid its bills during her absence demonstrated an "utterly careless attitude to the administration of the practice".
Taking account of the fact that Mrs Lindridge had not knowingly practised while unregistered, and the positive support of her clients, the Committee decided that a three-month period of suspension from the Register was appropriate.
Beverley Cottrell, chairing the Committee, commented: "The Committee would like to make it clear that it is the personal responsibility of every practising veterinary surgeon to ensure that the annual retention fee is paid and that their names are on the Register. It is in the public interest that clients should be assured that the practitioner is a regulated person, who is capable of providing valid certificates."
She continued: "The record of Mrs Lindridge's practice during 2007 discloses that she was providing certificates for horses and small animals whilst she was unregistered. Those certificates are invalid. She was also prescribing prescription-only drugs when she was not entitled to do so. The Committee considers that a short period of suspension is proportionate to the nature and the extent of the charge, the public interest and the interests of Mrs Lindridge."
Online registration for the BSAVA Congress 2011 is now open at www.bsava.com.
According to the BSAVA, web registration has been enhanced this year to provide a smoother process for individual, group and practice badge bookings. Plus, there is a 5% discount on registration fees.
BSAVA has brought forward the Early Bird deadline this year to 3 January 2011 to coincide with the impending VAT increase, so you'll need to register before this date to get the best price.
There is also a new 'Weekend Rate', which offers delegates access to the Saturday lectures, Party Night ticket, a Sunday exhibition pass, a delegate bag with proceedings, plus delegate lunch and refreshments on both days.
See www.bsava.com for further details and registration fees.
Dechra Veterinary Products has launched four new care products, enhancing its Professional Care range, available exclusively through veterinary practices.
The new products are:
Brand Manager Rachel Horton said: "At Dechra we're focused on providing a complete care solution for companion animals. Our Professional Care range provides products which owners can use at home to keep their pets in great condition.
With the launch of these new products, we believe the Professional Care range provides a cost-effective care solution for pet owners while providing significant additional revenue opportunities for practices."
1004 veterinary professionals attended VET Festival to hear talks from a line up of 21 speakers from around the world. On the Friday night, VETFest Live provided an opportunity for delegates to network and relax in front of a number of acts, including Hunter and the Bear, Lucy Spraggan and Morrissey & Marshall.
Noel said: "I think that change is inevitable within veterinary education. My experience with the students of today is that they wish to embrace new learning formats and are especially enthusiastic about learning environments where didactic lectures become an immersive experience. My goal therefore was to achieve the perfect mix of education and a chilled-out festival atmosphere.
"We are learning all the time, and we invite suggestions. I take very seriously the commitment I voiced in the welcome address, which is to reinvest every penny for the greater good for animals and the profession. I sincerely believe that vets and vet nurses will over time question where their money is spent and will take a good hard look not only at what value they get for their investment, but also where their money actually goes."
Picture: Richard Dunwoody.
The speakers are:
Dr Lappin said: “There are a number of significant changes in the management of SARS-CoV-2 that impact companion animal medicine and our staff members since our first webinar. I believe the information to be presented will be extremely valuable in helping your veterinary team continue to successfully navigate this pandemic.”
David Sutton, Global Technical Director at webinar sponsors MSD Animal Health, said “COVID-19 has presented an extraordinary challenge to the global community. MSD Animal Health is proud to support WSAVA in providing quality education to veterinary professionals who continue to go above and beyond in the care of companion animals during the pandemic.”
To register for the webinar, visit: http://bit.ly/wsavawebinar-covd19-registration
The Linnaeus OAPC initiative was launched in 2021 and originally allocated £30K for 2022.
However, that figure was doubled after the company received a growing number of high quality submissions.
33 papers were accepted for funding in 2022, of which 24 have so far been published and the remainder are undergoing peer review.
The authors comprise clinicians, specialists, residents and interns across nine referral and primary care sites within the group.
The OAPC was introduced by Professor Luisa De Risio, Clinical Research & Excellence Director at Linnaeus (pictured right).
She said: “By making clinical research open access, we can ensure it makes the widest possible impact – while also supporting the author’s profile and career development.
"We are continuing to offer OAPC funding to our associates in 2023 and look forward to seeing the fantastic research published as a result.”
They include the launch of the RCVS Academy, reforms to the RCVS concerns investigation process, the publication of the Workforce Action Plan and guidance for universities on supporting Black, Asian and Minority Ethnic veterinary students, ongoing work on new under care guidance, the development of new sustainability standards for the Practice Standards Scheme, and the purchase of the future headquarters for the RCVS.
The report also contains an update from the College’s charity partner RCVS Knowledge, details of RCVS financial management policies, and an independent auditor’s report on the College.
The Annual Report and Financial Statements will be formally adopted by RCVS Council at its Annual General Meeting on Friday 7th July at One Great George Street.
Veterinary surgeons and veterinary nurses are able to submit questions about the Annual Report.
The College says that subject to time, submitted questions will be answered by the College on the day, or followed up in writing after the event.
Questions should be emailed to Deborah Rowlanes, RCVS Events Manager, on d.rowlanes@rcvs.org.uk no later than 5pm on Tuesday 4th July.
If you want to attend, register at: www.rcvs.org.uk/events.
Time is running out to nominate your fellow staff members for this year's 'Petplan Pet Insurance Advisor Award'.
The award recognises the hard work and dedication that Pet Insurance Advisors (PIAs) do to highlight the importance of insurance to pet owners so that they are protected financially.
Donna Lewis, President of The British Veterinary Nursing Association said: "The PIA in a practice is an important role for a member of staff to fill and the award is just as relevant as the Vet Nurse of the Year or Receptionist of the Year award. The Petplan PIA Award recognises the individual who fully understands and works to help educate clients and staff about insurance, it is also recognises their passion for their role."
To nominate your dedicated PIA for Petplan's PIA of the Year Awards, please visit www.petplan.co.uk/pia. The PIA of the Year will receive a new laptop and their practice will receive £100 in vouchers!
Nominations close on 3rd September and the nominees will be judged by industry professionals. The winner will be announced at the annual BVNA Congress on 9th October.
The Royal Veterinary College is calling for dogs diagnosed with osteoarthritis to take part in a revolutionary study in which their movement will be monitored by a state-of-the-art recorder.
The recorder (pictured right), which is attached to the dog's collar, uses miniaturised sensors based on those found in smart phones. It can distinguish between different activities independent of the dog's location, allowing constant recording of movement in the dog's home environment, to complement the traditional clinical assessments carried out as part of the trial.
The study is being carried out to assess the efficacy of the joint mobility supplement Yumove in reducing the clinical signs of osteoarthritis. This will be the first time that the real effect of a joint supplement has been measured.
Dr. John Howie, co-founder of Lintbells, the company that makes Yumove, said: "This is the first time the real effect of a joint supplement has been measured and it will be a very fast trial. Yumove is a supplement that has been specifically formulated to include glucosamine, chondroitin and Omega 3 from green-lipped mussel, which all work together to increase joint mobility and provide an anti-inflammatory effect."
The research is being led by Dr Matthew Pead the RVC's Academic Director of Professional Assessment and Development. He said: "The results of this study will have important clinical implications for the understanding and treatment of canine OA, with the ultimate aim of advancing the treatment of this difficult and degenerative disease for the benefit of many thousands of dogs."
Any veterinary surgeon with a patient in their practice that might benefit from this study is invited to refer them. Further details are available the Clinical Investigation Centre at the Royal Veterinary College - email cic@rvc.ac.uk or phone 01707 666605.
Set up in 2012, the programme was developed to raise the standards of care and welfare of cats in the veterinary clinic, and to provide veterinary surgeons with practical solutions to problems that they face when dealing with their feline patients. The programme is also designed to boost business by strengthening the bond between the clinic and its feline clients.
Four years later, with 732 practices accredited worldwide (369 in the UK) and a further 1,000 US practices accredited under the American Association of Feline Practitioners scheme licensed from ISFM, the programme has become a well-recognised global standard in feline veterinary care. Last October, it was the winner of the 2016 Veterinary Record Innovation Award.
ISFM says it has now signed six new commercial partners for the scheme: Boehringer Ingelheim, Ceva Animal Health, Elanco, Idexx Laboratories, Merial and Royal Canin, and will be working with these partners to expand the programme further.
Dr Andy Sparkes, Veterinary Director of International Cat Care, ISFM’s parent charity, said: We are delighted to see how many clinics around the world have focused on becoming cat friendly and we can only expect this to grow again in 2017 with our new partners on board. We are looking forward to a very cat friendly 2017!"
Clinics interested in joining the scheme should visit: www.catfriendlyclinic.org for further information, including an extensive library of photographs from already-accredited clinics to provide inspiration and ideas.
The partnership happened after Lumbry Park’s Clinical Director, veterinary cardiologist, Dr Luca Ferasin and his wife Heidi had a son, Mattia, with multiple and life-threatening congenital heart defects. During their son's subsequent treatment, which involved seven hours of successful open heart surgery, Dr Ferasin and his wife got to know Dr Caner Salih, a consultant paediatric cardiac surgeon and member of the team caring for Mattia. So when Dr Salih acquired French Bulldog puppy called Büdu a few weeks later, and a heart murmur was detected during his first visit to the vet, he turned to Dr Ferasin for advice.
Dr Ferasin diagnosed Büdu with the congenital heart condition Perimembranous Ventricular Septal Defect (VSD). A VSD is characterised by a hole between the left and right ventricles of the heart which causes an abnormal blood flow between the two chambers. Ironically, a large VSD was one of the multiple heart defects successfully corrected during Mattia’s life-saving cardiac surgery.
Dr Salih said: "I first met Dr Ferasin and Heidi under one of the most stressful circumstances a parent can experience, that of waiting for a child to undergo life-saving cardiac surgery. Sometime later I had first-hand experience of something not comparable but nonetheless very stressful of having to wait for the results of a diagnostic test which Dr Ferasin was able to provide for our newly acquired puppy. I appreciated more than ever the importance of knowing that our newest family member was in the most capable of hands."
Dr Ferasin said: "The related stories of Mattia and Büdu highlight the remarkable similarities between paediatric and small animal medicine, not only in terms of medical conditions, diagnostic techniques and therapeutic procedures, but also in terms of the psychological, emotional and social importance of the human-animal bond – in both directions. After all, just like babies and young children, veterinary patients cannot communicate with us - while their ‘parents’ have the same need for reassurance that their beloved ‘baby’ will recover.
"Our partnership with the Evelina London Children’s Hospital will celebrate these similarities and promote the concept of ‘One Health’ in a bid to advance both human and veterinary medicine. By working closely with the Evelina London, we aim to contribute positively to the development of novel techniques, research and therapies in both our children and in companion animals. We’re planning a range of initiatives, including fundraising and collaborations with the clinical staff at Lumbry Park and the Evelina London, in particular with those in the cardiology and cardiac surgery departments. We’re also planning social events, such as advanced pet-therapy sessions for children undergoing treatment at the Evelina and their families, including direct interaction with our veterinary patients with similar conditions."
He added: "Thanks to the dedicated team at the Evelina London Children’s Hospital, Mattia is thriving and is a happy, healthy and fun-loving little boy. He will continue to visit the hospital for reassessments as he grows. Büdu visited us again at Lumbry Park during 2016 for a reassessment and an ultrasound of his heart showed the spontaneous closure of his VSD, resulting in the resolution of his condition. This is a rare but fantastic outcome which, to the best of our knowledge, has only been reported in a couple of canine cases in the veterinary literature. What better reason to cement the bond between human and veterinary medicine!"
Dr Salih added: "Many people do not appreciate the amount of shared learning that has, for decades, occurred between the study of animals and medicine. Many of the advances in areas of human healthcare we embrace today simply could not exist without this relationship – and open heart surgery is one. The Evelina is delighted to be collaborating with Lumbry Park on this exciting venture."
The new guidance replaces Chapter 25 of the Supporting Guidance to the Code of Professional Conduct.
Routine Veterinary Practice describes the procedures and techniques performed on animals by veterinary surgeons (or veterinary nurses under their direction) in the course of their professional duties, which ensure the health and welfare of animals committed to their care.
CVR is when routine procedures are undertaken for the benefit of the animal/s, with the concurrent intention to generate new knowledge that benefits animals, such as developing new procedures, improving a diagnosis, changing a routine procedure, or comparing existing procedures.
While the idea of CVR is not new, this is the first time that the RCVS has provided specific guidance on it.
The guidance also introduces an obligation, which comes into effect on 1st September, to obtain ethics review for all studies where one would be expected to obtain permission from the owner/keeper of an animal prior to being enrolled, or when consent is needed for use of previously collected samples or the use of data from an animal.
The newly drafted Chapter 25 gives extra guidance on the following areas:
Chair of the Standards Committee and incoming RCVS President, Dr Melissa Donald (pictured right), said: “We hope that the guidance will inspire confidence in our veterinary colleagues at all levels to undertake treatment routes which develop veterinary knowledge as a whole, while still being for the benefit of the animal being treated.”
For further information or advice on whether a proposed procedure would be covered by the guidance, contact the Standards and Advice team via advice@rcvs.org.uk.
The new guidance will be found on the RCVS website from the 1st July: www.rcvs.org.uk/recognised
For further information in relation to ethics review of proposed veterinary clinical research studies, contact the Secretary to the RCVS Ethics Review Panel via ethics@rcvs.org.uk or visit www.rcvs.org.uk/ethics
A new programme to help reduce the stress of pets suffering a reaction to sudden loud noises such as fireworks and thunderstorms, has been launched by the makers of Zylkène.
Intervet / Schering-Plough Animal Health, which manufactures Zylkène, a product to help manage stress in dogs and cats, has developed the programme in association with animal behaviour experts at Bristol University.
The Zylkène Sound Desensitisation Programme, to be used in conjunction with Zylkène, features sound tracks, advice, written and verbal instructions and a practice track designed to help pet owners find a long-term solution to a common and distressing problem. The CD features fireworks, thunder and lightening and gunshots sounds and includes component sound tracks to avoid overwhelming very sensitive pets.
One CD will be given away free of charge with every box of Zylkène purchased between 1 September and 30 November, while stocks last.
The Zylkène Sound Desensitisation Programme complements an educational waiting room display and owner information sheets which provide owners with practical advice and techniques to help pets cope throughout the firework season.
Melanie Dass, product manager at Intervet /Schering-Plough Animal Health, said: "The sad fact is that just under half the UK dog population reacts to sudden loud noises, as do many cats. Stress caused by unexpected sounds manifests in many ways from hiding, house soiling or attempts to escape.
"Unfortunately, if this problem is not correctly managed, firework-related stress reactions can become progressively more severe and can extend to other sounds such as thunder and even everyday noises such as car doors being slammed. Desensitisation is a proven method of changing a pet's response to sudden loud noises. This new Zylkène Sound Desensitisation Programme means we can now offer pet owners short and long term problems to a common and distressing problem."
Fort Dodge Index (FDI) data for the first six months of 2009 confirm the downward trend in key veterinary practice metrics, including turnover growth, transaction volume and client numbers with a national picture emerging of much slower growth than the same time last year. The one mitigating factor continues to be an increase in the prices charged by practices for their services, which is leading to a small increase in average transaction values.
The FDI (www.fortdodgeindex.co.uk) analyses and benchmarks the performance of practices across the UK. Figures for the first half of 2009 confirm the trend, seen for some time, of static or steadily declining performance in key areas for practices. The national picture of turnover growth and its components for the period January-June 2009 shows that:
Patrick Traill, Corporate Account Manager at Fort Dodge, said: "While some practices are continuing to report busy months and high turnover, it's clear that many are experiencing a rough ride as the recession in the wider economy affects the spending power of pet owners.
"The key challenge is that profits are being eroded at a time when turnover is also being seriously hit. The only impetus for growth so far this year has been the increase in consulting, surgical and drug fees and this alone will not help practices plan for a secure future.
"The latest FDI data confirms a trend which we've been reporting for some time and we urge those who haven't yet taken action to do so without delay. While capturing new clients will always be fundamental to growth, in these times reducing client losses is equally critical and resource may well be better spent on plans that support client retention.
"Practices should also be considering initiatives to increase client visit frequency and support client bonding. Examples could include preventative health schemes and loyalty programmes. Finally, practices could also explore avenues to increase annual transaction value through the promotion of new products and services.
"Joining the FDI is an effective way for practices to benchmark their performance both against others in their locality and across the UK. Full details on the FDI, the benefits it offers to practices and how to join are available on our newly re-designed website. Full copies of the FDI report can also now be downloaded on a quarterly basis."
A copy of the latest FDI report is available for free download at http://www.fortdodgeindex.co.uk/. Further information on how to join the scheme is available from Fort Dodge on 01489 781811.
Woodley Equipment Company has become the exclusive Europe-wide distributor for the new Epoc Hand Held Clinical Care Analyser from Epocal Inc
Woodley says the Epoc, developed by the founder of the i-STAT analyser, is the first wireless point of care testing solution to use smart card technology. The Epoc provides immediate blood gas, electrolyte and critical care biochemistry results directly to a hand held PDA (included) and wirelessly interfaces with your in-practice computer. It is a completely affordable analyser that is easy to use and requires no refrigeration of consumables.
Key Features:
For a more information about the Epoc Blood Gas Analyser please email sales@woodleyequipment.com, visit woodleyequipment.com, or call Woodley's customer service team on +44 (0)1204 669033 ~ Option 1
The publicly supported Dog Control Bill moves a step closer towards changing dangerous dog legislation for good as it reaches Report Stage in the House of Lords today.
Over 10,000 people signed up to support it and animal welfare organisations and charities throughout the UK are backing it; Lord Redesdale's Dog Control Bill would replace the widely criticised Dangerous Dogs Act (1991), by targeting the inappropriate behaviour of any dog, and more importantly the owners of such dogs, to reduce the occurrence of serious dog incidents, rather than continuing to demonise specific breeds or types.
The Bill is championed by the Dangerous Dogs Act Study Group (DDASG), a wide-ranging group representing animal welfare, local authorities and veterinary professional organisations who have been actively involved in resolving the inadequacies of the current 'dangerous dog' legislation for many years.
The DDASG considers that the Dangerous Dogs Act needs to be overhauled to better protect the public and that a new dog control regime which emphasises responsible dog ownership should be introduced.
DDASG Chairman Chris Laurence said: "We have had considerable input into the Dog Control Bill and are confident that the Bill takes huge steps towards changing the manner in which owners of dogs that are out of control will be dealt with; the emphasis being on the prevention of dog bites."
The Report Stage of the Dog Control Bill is listed as the first item of business in the House of Lords on this morning and comes as Defra's public consultation on dangerous dogs shows further support for this approach with 71% of respondents calling for breed specific legislation to be repealed.
In support of the Bill, the DDASG launched a petition which has received over 10,000 signatures. The petition can be found at http://www.gopetition.com/petitions/repeal-and-replace-the-dangerous-dogs-act.html. The DDASG has also been working with other major stakeholders including the Royal Society for the Prevention of Cruelty to Animals and will be issuing a joint briefing to government tomorrow, entitled 'Finding solutions to irresponsible dog ownership' which outlines where urgent action must be taken in existing dog legislation to improve huge inadequacies within the law.
Subject to the Bill passing the Report Stage, the Third Reading will take place after summer recess before moving to the House of Commons for further consideration. For more information on the DDASG, Lord Redesdale's Dog Control Bill and current legislation, visit http://www.thekennelclub.org.uk/item/928.
The trial starts on Monday 11 July and will continue for three months to allow the College to determine levels of demand for such a service and, therefore, whether it should be made permanent.
Eleanor Ferguson, RCVS Acting Registrar, said: "This was a potential service identified in our Strategic Plan as a way of allowing veterinary professionals to have informal, confidential, discussions with members of the Professional Conduct Department about potential fitness to practise issues, short of formally raising a concern.
"Although any discussions via the new reporting line or email address will be confidential, if a veterinary surgeon or a veterinary nurse subsequently wishes to raise a formal concern about another veterinary professional, then they generally will need to identify both themselves and the individual in order to take it through our investigation process.
"We have developed a bespoke concerns form for members of the professions who do want to raise concerns about other professionals."
Veterinary surgeons and veterinary nurses who wish to contact a member of the RCVS Professional Conduct Department in confidence can do so by calling 07599 958 294 between 9am and 5pm, or by emailing reporting@rcvs.org.uk.
The bespoke concerns from for members of the profession can be downloaded from www.rcvs.org.uk/concerns.
The audit1 was led by Paragon Veterinary Referrals’ head of cardiology, Chris Linney (pictured), to review treatment for patent ductus arteriosus.
He set up the study whilst working at Willows Veterinary Centre and Referral Service, and the other centres collaborating on the study were Anicura Oslo Animal Hospital, Heart Vets; Royal (Dick) School of Veterinary Studies and the Roslin Institute, University of Edinburgh, University Hospital of Companion Animals, Copenhagen and Veterinary Cardiology Consultancy.
Other clinicians taking part included Brigite Pedro, Mike Martin and João Neves, formerly of Willows, along with Jo Harris and Dave Dickson, of HeartVets.
Chris, an RCVS and EBVS specialist in cardiology, said: “This published multicentre prospective clinical audit was a first of its kind in the cardiology world.
“This type of audit acts as a quality control to improve patient outcomes through systematic review of care, comparing to predefined criteria and then implementing change, and so the process repeats.
“Improving patient outcomes and benchmarking against existing standards is essential for elevating patient outcomes.
In the centres in this study, we are already delivering excellent patient outcomes but with room for improvements, however small, this audit will help future patients but also colleagues across the cardiology world.”
Reference
Merial has launched Equioxx, a new pain management product which the company says is the first COX-2 specific NSAID for horses
Traditional NSAIDs act by blocking the action of both COX-1 and COX-2 enzymes at the same time. Although COX-2 produces prostaglandins associated with both inflammation and pain, COX-1 has a pivotal role in maintaining normal physiological function, so inhibiting this enzyme may have an increased risk of side effects e.g. gastric ulceration. Merial says Equioxx is the only NSAID that is highly COX-2 selective (up to 643 times more selective for COX-2 than COX-1), acting to reduce pain and inflammation but without affecting the COX-1 enzyme at therapeutic levels.
Equioxx contains the active ingredient firocoxib, and Merial says it is proven to be effective at reducing chronic lameness in horses. Appearing in blood plasma within 30 minutes of oral dosing, its pharmacokinetic profile allows once daily dosing. Field studies have confirmed that firocoxib is highly effective at controlling pain and improving function in horses with chronic osteoarthritis.
Equioxx is available as either a low dose injectable solution or a palatable oral paste.
For more information contact Merial Customer Services on 0870 6000 123
Henry Schein Inc. has announced an agreement to acquire RxWorks Inc., the veterinary practice management software provider.
Founded in 1988 and with headquarters in Brisbane, Queensland, Australia, RxWorks has 68 team members and an installed base of more than 1,500 veterinary clinics in 19 countries worldwide (primarily Australia, New Zealand, the UK and the Netherlands).
Henry Schein says RxWorks will become part of it's Global Animal Health Practice Solutions business, led by its current management team.
Stanley M. Bergman, Chairman of the Board and Chief Executive Officer, Henry Schein, Inc. said: "RxWorks has an excellent reputation for helping veterinarians increase practice efficiency and improve quality health care through its innovative practice management software solutions.
"The addition of RxWorks further strengthens our growing practice management software solutions business, which helps deepen relationships in the regions served by RxWorks with our animal health customers, including large corporate customers. The addition of RxWorks will nicely complement our expanding animal health technology businesses. We look forward to welcoming our new colleagues from RxWorks to Henry Schein."
Nathan Basha, Chairman of RxWorks said: "RxWorks software is designed to facilitate consistency of patient care, enable practice growth, achieve enhanced profitability and optimize professional time, all the while improving the quality of life for patients. Aligning with Henry Schein, a global company committed to serving animal health professionals and bringing innovation to the marketplace, allows RxWorks to provide even further value to customers while expanding industry reach."
Henry Schein says it expects the acquisition to close in the second half of January 2016. Financial details and terms of the transaction were not disclosed.
Intervet/Schering-Plough Animal Health has announced that it has received approval for the intramuscular (IM) route of administration of Nuflor Minidose 450 mg/ml, a florfenicol-containing broad-spectrum antibiotic for the management of bovine respiratory disease (BRD).
Nuflor Minidose was approved initially in 2008 for subcutaneous (SC) use only and the now approved IM administration route is a line extension. According to Intervet/Schering Plough, IM administration (20 mg/kg administered twice, 48h apart) offers additional flexibility for the veterinary surgeon when treating cattle for BRD.
The company adds that Nuflor Minidose is the florfenicol injectable formulation which offers the lowest injection volume, which in particular is practical when treating heavier animals (thereby avoiding large injection volumes). The withdrawal period after IM administration of NUFLOR Minidose is only 37 days and is considerably shorter as compared to 64 days after SC use (40 mg/kg body weight injected once).
Francis Adriaens, Global Marketing Director, Global Ruminants Business Unit at Intervet/Schering-Plough Animal Health said: "Our customers requested the IM claim when Nuflor Minidose was first introduced and we are delighted to be able to recommend this route of administration hence forth."
Nuflor Minidose is indicated for preventive and therapeutic treatment of BRD in cattle caused by Mannheimia haemolytica, Pasteurella multicoda and Histophilus somni susceptible to florfenicol. The presence of the disease in the herd should be confirmed before administering preventive treatment.
Elanco Companion Animal Health, maker of Comfortis, has launched a new campaign to raise awareness of the perennial problem of fleas, and the importance of regular treatment.
The campaign revolves around some new research which shows that while nearly half of dog owners1 allow their pets to swim at least once a month during the summer, over 45% of those questioned were unaware that if a dog is bathed or swims it may lose protection from spot-on flea treatments with only a sixth realising that the active ingredients in some spot-on insecticides can harm aquatic organisms2.
Gavin and Stacey actress Joanna Page, and RSPCA veterinary surgeon David Grant (pictured right) are being wheeled out to talk about the new research, both on the radio and on web TV.
In addition, Elanco says that a range of Comfortis support materials are available to help educate pet owners about fleas and the healthcare issues associated with fleas and encourage enquiries about flea control solutions.
For further information please contact your local Elanco Companion Animal Health key account manager or email elancoah.uk@lilly.com.
References
Modules for the first GPAdvCert – in Small Animal Orthopaedics – will begin in February 2018. Improve says it's the first of many 'next steps' programmes which it plans to launch under this new postgraduate level qualification.
The GPAdvCert in Small Animal Orthopaedics is aimed at veterinary surgeons who have completed their General Practitioner Certificate in Small Animal Surgery (GPCert SAS) or Postgraduate Certificate (PgC) in Small Animal Surgery.
Accredited by the European School of Veterinary Postgraduate Studies (ESVPS) and validated by Harper Adams University, the programme is delivered over 15 modules in three state-of-the-art European training centres - Sheffield, UK, Cremona, Italy and Madrid, Spain. Improve says delegates will learn from world-class clinicians and will be supervised in their practise of new surgical techniques and advanced procedures in a wet-lab environment.
David Babington MRCVS, Managing Director of Improve International (pictured right), said: "We felt there was a gap in the current structure for a postgraduate qualification which would allow students to advance their knowledge and practical skills in their chosen area and to add to their academic credentials. The General Practitioner Advanced Certificate is our solution."
Successful achievement of the GPAdvCert will enable delegates to progress from a Postgraduate Certificate in Small Animal Surgery (or equivalent) to the Postgraduate Diploma in Advanced Veterinary Practice Sciences in the UK, which is awarded by Harper Adams University. This can, in turn, be used towards the award of a Masters Degree (MSc) in Advanced Veterinary Practice Sciences.
David added: "Delegates for our first GPAdvCert in Orthopaedics for Small Animals will enhance their skills and confidence in dealing with more advanced orthopaedic procedures in-house and this will help them to reduce the number of patients which are referred, retaining a higher level of income for their practice. They will also develop skills which they can pass onto their team. We look forward to welcoming our first delegates next year."
Further details are available at: https://www.improveinternational.com/uk/course/general-practitioner-advanced-certificate-in-small-animal-orthopaedic-surgery/
The Brexit Barometer report draws on insights from 16 animal medicines companies and other stakeholders. 95% of those who contributed to the report, drawn up after NOAH’s Brexit event in May, said that they are optimistic about the future of animal health and welfare in the UK.
On the broader future of the industry, contributors to the report were more uncertain: 40% 'in the middle', 30% 'optimistic' and 25% 'pessimistic'. In contrast to animal welfare, contributors were most pessimistic about the future of trade and exports in relation to animal health.
While optimism about animal welfare remains high, NOAH says the animal medicines industry needs a continuation of its high standards of health and welfare to help tackle antibiotic resistance and to put the UK in a strong influencing position with our ability to trade. Six key measures in relation to health and welfare that Government needs to take to realise the opportunities were outlined in the report. They are:
• Maintaining the current Animal Welfare Acts and evolving them to secure the UK’s position from ‘Day 0’• Ensuring the industry is not disadvantaged by lack of veterinary medicines availability during the transition period and beyond, as new products come on the market• Ensuring that veterinary services are available in inner city and rural areas throughout the UK• Ensuring that a cross-border programme is in place to maintain cooperation between the UK and Europe• Recognising that animal diseases do not respect borders and to co-operate with our European neighbours to ensure that appropriate measures are in place to prevent and control disease outbreaks• Balancing first-class welfare standards with creating a level playing field for UK farmers and ensuring that British product does not become uncompetitive.
NOAH Chief Executive, Dawn Howard said: "While the Barometer showed that a large proportion of the industry was undecided when it comes to overall future of our sector, it tells us loudly and clearly that the sector sees a very clear opportunity for the UK to show leadership when it comes to animal health and welfare. What is vital now is that Government collaborates closely with industry and heeds its advice to realise this opportunity and leverage these high levels of optimism. We must not forget that veterinary medicines support the health and welfare of the UK’s livestock and pets and we stand ready to work with industry and Government to help make this happen."
BVA President Gudrun Ravetz said: "We have a unique selling point as 'UK PLC' around our high standards of animal welfare and food safety and these must be maintained in the wake of Brexit. This means tackling issues including veterinary involvement from farm to fork to underpin animal health, welfare and public health, through to guaranteeing working rights for vets and veterinary nurses. It is therefore vital that animal welfare is included in all trade negotiations."
The report can be read in full here: https://www.noah.co.uk/wp-content/uploads/2017/07/NOAH-Brexit-Barometer-Summer-17-6pp-A4-vf.pdf